Pharmaceutical Expenditure and Therapeutic Value of New Medicines in Spain

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.21, Iss.16, 2003-01, pp. : 1211-1212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Overview of the European Union's New Medicines Legislation: Implications for the Pharmaceutical Industry

By Jackman Margaret Woods Kent

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite

Influence of the National Hospital Pharmaceutical Strategy on the Assessment of New Medicines in New Zealand Public Hospitals

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 4, 2005-12 ,pp. : 271-275

John Wiley & Sons Inc

Access to resources Recommend Favorite

Assessing the Value of Medicines

By Sansom Lloyd

Pharmaceutical Medicine, Vol. 24, Iss. 2, 2010-04 ,pp. : 89-92

Adis International

Access to resources Recommend Favorite

A record £3.5 billion was spent by the British pharmaceutical industry in 2003 in the search for new medicines

Inpharma, Vol. 1, Iss. 1432-1433, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

A record £3.5 billion was spent by the British pharmaceutical industry in 2003 in the search for new medicines

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 450, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite